Acarix looks towards Germany and enters alliance with health management company
The Coloplast-spinout Acarix has signed a deal with German Med Management to distribute the Danish company's diagnostic tool Cadscor to the German market, which is worth more than EUR 100 million.
The Danish medtech company Acarix is busy preparing the launch of its main asset on the European markets, including Germany where the market generates more than EUR 100 million (USD 113.81 million).
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Coloplast spin-off prepares to launch lead product
For abonnenter
